source
- AI-driven biotech Enveda secures $311 million Series E to advance plant-derived drug candidatesEnveda Biosciences, a Colorado AI drug discovery company, announced a $311 million Series E financing round, one of the larger biotech raises this year. The firm uses artificial intelligence to sc…
- FDA issues early alert on Abiomed Impella controller safety issueThe FDA Center for Devices and Radiological Health (CDRH) has posted an Early Alert about a potential high risk problem with certain Abiomed Impella automated controllers. Abiomed has sent a lette…